The life science group Sartorius today released its Annual Report for 2024. The document is available at the following link: Financial ...

As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

Morgan Stanley (NYSE:MS) upgraded Sartorius AG (ETR:SATG) (SRT3:GR) (OTC: SARTF), a prominent player in the bioprocessing industry, from Equalweight to Overweight, while also increasing the price ...

TD Cowen began coverage on Repligen Corporation (NASDAQ:RGEN), a prominent bioprocessing company, with a Buy rating and a price target set at $200. The firm highlighted Repligen's strong position for ...

The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share for fiscal 2024. Dividend payment on April 1, 2025 ...

EQS-News: SARTORIUS AG / Key word (s): Dividend The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share (news with additional features) 07.02.2025 / 15:48 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on ...

CapEx for R&D and Infrastructure: EUR340 million, with a CapEx ratio of 12.2%. Sartorius AG (SARTF) achieved its reverse guidance for 2024, with both top-line and profitability meeting expectations.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

EQS Preliminary announcement financial reports: SARTORIUS AG / Preliminary announcement on the disclosure of financial statements Sartorius AG: Preliminary announcement of the publication of ...

Tuesday, Sartorius AG (ETR:SATG) (SRT3:GR) (OTC: SARTF) stock remained under the scrutiny of Bernstein SocGen Group, as the firm reiterated its Underperform rating and a price target of EUR194.00. The ...